Youngbo Chemical Co., Ltd. (014440.KS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	125.3B	120.1B	117.6B	90.3B	83.0B
Cost of Revenue	88.5B	83.2B	81.6B	67.5B	62.7B
Gross Profit	36.8B	36.9B	36.0B	22.8B	20.3B
Operating Expenses
R&D Expense	2.3B	2.3B	1.8B	2.0B	2.0B
SG&A Expense	7.9B	5.9B	6.0B	5.3B	3.2B
General & Admin Expense	1.4B	2.0B	2.0B	1.7B	(1.7B)
Selling & Marketing Expense	2.8B	4.0B	4.0B	3.6B	4.8B
Other Expenses	7.3B	9.4B	8.7B	8.6B	10.2B
Total Operating Expenses	17.5B	17.6B	16.6B	14.6B	15.3B
Cost and Expenses	106.0B	100.8B	98.2B	82.2B	78.0B
Operating Income (EBIT)	19.3B	19.3B	19.4B	8.1B	5.0B
Non-Operating
Interest Income	1.3B	1.4B	1.5B	730.5M	676.0M
Interest Expense	6.6M	6.7M	35.0M	95.4M	189.8M
Net Interest Income	1.3B	1.4B	1.4B	632.2M	486.2M
Other Non-Op Income/Expense	3.8B	1.5B	2.4B	(1.1B)	2.5B
Non-Operating Income (excl Interest)	(1.7B)	—	(2.4B)	1.0B	(2.7B)
EBT (Pre-Tax Income)	23.1B	20.7B	21.8B	7.0B	7.5B
Income Tax Expense	4.8B	3.9B	2.8B	915.5M	415.0M
Bottom Line
Net Income	18.3B	16.8B	22.6B	6.0B	6.7B
Earnings from Cont. Ops	18.3B	16.8B	19.1B	6.1B	7.1B
Earnings from Discont. Ops	—	—	3.5B	(118.0M)	—
Bottom Line Net Income	18.3B	16.8B	22.6B	6.0B	6.7B
Per Share
Basic EPS	₩938	₩863	₩1,160	₩306	₩343
Diluted EPS	₩938	₩863	₩1,160	₩306	₩343
Revenue Per Share	₩6,427	₩6,159	₩6,029	₩4,630	₩4,256
Shares
Basic Shares Outstanding	19.5M	19.5M	19.5M	19.5M	19.5M
Diluted Shares Outstanding	19.5M	19.5M	19.5M	19.5M	19.5M
Profitability Metrics
EBITDA	29.8B	28.2B	30.6B	15.4B	16.3B
D&A	9.5B	8.9B	8.7B	8.3B	8.7B
EBIT	20.3B	19.3B	21.8B	7.1B	7.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026